Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
JAMF
|
Anthony Grabenau
CAO |
SELL
Open market or private sale
|
Direct | 3,706 Reduced 9.97% |
$52,365
$14.13 p/Share
|
Jan 16
2025 |
|
MARA
|
Frederick G Thiel
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 27,505 Reduced 0.67% |
$495,365
$18.01 p/Share
|
Jan 16
2025 |
|
LUNG
|
Glendon E. French Iii |
SELL
Open market or private sale
|
Direct | 2,326 Reduced 0.22% |
$15,188
$6.53 p/Share
|
Jan 16
2025 |
|
RBLX
|
Amy Marie Rawlings
Chief Accounting Officer |
SELL
Open market or private sale
|
Direct | 5,879 Reduced 7.22% |
$382,135
$65.0 p/Share
|
Jan 16
2025 |
|
TYRA
|
Nina S Kjellson |
SELL
Open market or private sale
|
Indirect | 7,779 Reduced 0.0% |
$126,719
$16.29 p/Share
|
Jan 16
2025 |
|
RBLX
|
Mark Reinstra
Chief Legal Off. & Corp. Sec. |
SELL
Open market or private sale
|
Direct | 50,000 Reduced 15.1% |
$3,249,000
$64.98 p/Share
|
Jan 16
2025 |
|
CARG
|
Langley Steinert
Executive Chair |
SELL
Open market or private sale
|
Indirect | 5,042 Reduced 0.0% |
$189,831
$37.65 p/Share
|
Jan 16
2025 |
|
CARG
|
Langley Steinert
Executive Chair |
SELL
Open market or private sale
|
Direct | 45,407 Reduced 5.11% |
$1,709,573
$37.65 p/Share
|
Jan 16
2025 |
|
AGYS
|
Kaufman 2012 Descendants Trust, David N. Smith, Trustee |
SELL
Open market or private sale
|
Direct | 7,500 Reduced 2.77% |
$1,002,825
$133.71 p/Share
|
Jan 16
2025 |
|
ZYME
|
Eco R1 Capital, LLC
Director |
BUY
Open market or private purchase
|
Indirect | 121,681 Added 0.0% |
$1,688,932
$13.88 p/Share
|
Jan 16
2025 |
|
RYAN
|
Nicholas Dominic Cortezi
Director |
SELL
Open market or private sale
|
Indirect | 35,000 Reduced 0.0% |
$2,337,300
$66.78 p/Share
|
Jan 16
2025 |
|
FSLY
|
Ronald W Kisling
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 6,038 Reduced 1.15% |
$57,059
$9.45 p/Share
|
Jan 16
2025 |
|
SEZNL
|
Karen Hartje
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 3,457 Reduced 8.96% |
$1,093,518
$316.32 p/Share
|
Jan 16
2025 |
|
SRRK
|
Junlin Ho
GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct | 9,039 Reduced 4.43% |
$399,523
$44.2 p/Share
|
Jan 16
2025 |
|
SRRK
|
Edward H Myles
COO & CFO |
SELL
Open market or private sale
|
Direct | 12,539 Reduced 7.78% |
$554,223
$44.2 p/Share
|
Jan 16
2025 |
|
SRRK
|
Caryn Parlavecchio
CHRO |
SELL
Open market or private sale
|
Direct | 6,434 Reduced 4.23% |
$284,382
$44.2 p/Share
|
Jan 16
2025 |
|
CHWY
|
Sumit Singh
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 7,228 Reduced 1.36% |
$271,122
$37.51 p/Share
|
Jan 16
2025 |
|
SRRK
|
Mo Qatanani
CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct | 7,347 Reduced 5.15% |
$324,737
$44.2 p/Share
|
Jan 16
2025 |
|
SRRK
|
Tracey Sacco
Chief Commercial Officer |
SELL
Open market or private sale
|
Direct | 3,890 Reduced 7.89% |
$171,938
$44.2 p/Share
|
Jan 16
2025 |
|
SRRK
|
Jing L. Marantz
CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct | 5,655 Reduced 7.76% |
$249,951
$44.2 p/Share
|
Jan 16
2025 |
|
SRRK
|
Jay T. Backstrom
CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct | 22,308 Reduced 6.33% |
$986,013
$44.2 p/Share
|
Jan 16
2025 |
|
FIVE
|
Eric M Specter
CAO |
SELL
Open market or private sale
|
Direct | 5,494 Reduced 8.75% |
$498,635
$90.76 p/Share
|
Jan 16
2025 |
|
AEO
|
Cary D Mcmillan
Director |
SELL
Open market or private sale
|
Direct | 2,999 Reduced 100.0% |
$48,043
$16.02 p/Share
|
Jan 16
2025 |
|
SNX
|
Ann F Vezina
Director |
SELL
Open market or private sale
|
Direct | 839 Reduced 14.73% |
$114,171
$136.08 p/Share
|
Jan 16
2025 |
|
ONTO
|
Michael P Plisinski
CEO |
SELL
Open market or private sale
|
Direct | 30,000 Reduced 13.92% |
$6,350,400
$211.68 p/Share
|
Jan 16
2025 |
|
SNX
|
Dennis Polk
Hyve Solutions Executive |
SELL
Open market or private sale
|
Direct | 22,000 Reduced 35.54% |
$3,005,200
$136.6 p/Share
|
Jan 16
2025 |
|
OFIX
|
Julie Andrews
CFO |
SELL
Open market or private sale
|
Direct | 4,655 Reduced 14.12% |
$83,277
$17.89 p/Share
|
Jan 16
2025 |
|
HIMS
|
Andrew Dudum
Chief Executive Officer |
SELL
Open market or private sale
|
Indirect | 47,534 Reduced 0.0% |
$1,289,122
$27.12 p/Share
|
Jan 16
2025 |
|
HIMS
|
Andrew Dudum
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 36,460 Reduced 56.63% |
$990,618
$27.17 p/Share
|
Jan 16
2025 |
|
KLXE
|
Keefer Mc Govern Lehner
Officer |
SELL
Open market or private sale
|
Direct | 2,500 Reduced 2.78% |
$16,675
$6.67 p/Share
|
Jan 16
2025 |
|
CBIO
|
Songjiang Ma
President |
SELL
Open market or private sale
|
Indirect | 2,000 Reduced 0.0% |
$21,420
$10.71 p/Share
|
Jan 16
2025 |
|
PLAB
|
Kang Jyh Lee
CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct | 8,750 Reduced 1.51% |
$213,500
$24.4 p/Share
|
Jan 16
2025 |
|
QK
|
Hrt Financial LP
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 10,654 Added 27.57% |
$9,801
$0.92 p/Share
|
Jan 16
2025 |
|
GRX
|
Mario J Gabelli
Director |
BUY
Open market or private purchase
|
Direct | 4,000 Added 1.67% |
$39,200
$9.8 p/Share
|
Jan 16
2025 |
|
NXJ
|
Saba Capital Management, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 50,043 Reduced 0.0% |
$603,518
$12.06 p/Share
|
Jan 16
2025 |
|
MIO
|
Saba Capital Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 6,637 Added 0.0% |
$78,582
$11.84 p/Share
|
Jan 16
2025 |
|
SCWO
|
Yaacov Nagar |
SELL
Open market or private sale
|
Direct | 300 Reduced 0.0% |
$189
$0.63 p/Share
|
Jan 16
2025 |
|
IZTC
|
Michael Heltzen
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 121 Added 5.44% |
$1,297
$10.72 p/Share
|
Jan 16
2025 |
|
QMCO
|
Henk Jan Spanjaard
Chief Revenue Officer |
SELL
Open market or private sale
|
Direct | 935 Reduced 5.9% |
$33,360
$35.68 p/Share
|
Jan 16
2025 |
|
QMCO
|
James J Lerner
President & CEO |
SELL
Open market or private sale
|
Direct | 2,511 Reduced 2.28% |
$89,592
$35.68 p/Share
|
Jan 16
2025 |
|
QMCO
|
Brian E Cabrera
SVP Chief Admin Ofcr & Secy |
SELL
Open market or private sale
|
Direct | 1,996 Reduced 6.67% |
$71,217
$35.68 p/Share
|
Jan 16
2025 |
|
QMCO
|
Kenneth P. Gianella
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 1,487 Reduced 4.23% |
$53,056
$35.68 p/Share
|
Jan 16
2025 |
|
NYC
|
Nicholas S Schorsch
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 1,367 Added 0.0% |
$12,412
$9.08 p/Share
|
Jan 16
2025 |
|
PNRG
|
Clint Hurt
Director |
SELL
Open market or private sale
|
Direct | 739 Reduced 0.56% |
$158,781
$214.86 p/Share
|
Jan 16
2025 |
|
SKYH
|
Boston Omaha Corp
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 23,907 Reduced 0.22% |
$269,431
$11.27 p/Share
|
Jan 16
2025 |
|
IONS
|
Joseph Baroldi
EVP, Chief Business Officer |
SELL
Open market or private sale
|
Direct | 3,401 Reduced 11.97% |
$111,212
$32.7 p/Share
|
Jan 16
2025 |
|
IONS
|
Joseph Baroldi
EVP, Chief Business Officer |
SELL
Open market or private sale
|
Indirect | 1,029 Reduced 0.0% |
$33,648
$32.7 p/Share
|
Jan 16
2025 |
|
IONS
|
C Frank Bennett
EVP, Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 6,752 Reduced 6.92% |
$222,140
$32.9 p/Share
|
Jan 16
2025 |
|
IONS
|
Brian Birchler
EVP, Corp and Development Ops |
SELL
Open market or private sale
|
Direct | 5,400 Reduced 8.93% |
$176,580
$32.7 p/Share
|
Jan 16
2025 |
|
IONS
|
Shannon L. Devers
EVP, Chief Human Resources Ofc |
SELL
Open market or private sale
|
Direct | 4,267 Reduced 21.12% |
$139,872
$32.78 p/Share
|
Jan 16
2025 |